Kanyos Bio, Inc.   Report issue

For profit Phase 1
Founded: Cambridge MA United States (2015)
Status: Acquired by Anokion SA (2019)

Organization Overview

First Clinical Trial
2020
NCT04248855
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA